The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

Walgreens Boots Alliance has a storied history in Chicago, starting with a single retail outlet in 1901, and expanding across ...

Express Scripts said the legal action was "reckless ... chief legal officer at Cigna. CVS Caremark said that preventing PBMs from negotiating drug prices will only benefit pharma companies ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

When asked about restrictions on supportive care medications, a spokesman for CVS Caremark, one of the nation’s largest ...